Literature DB >> 23640423

Genetic polymorphism in FOXP3 gene: imbalance in regulatory T-cell role and development of human diseases.

Julie Massayo Maeda Oda1, Bruna Karina Banin Hirata, Roberta Losi Guembarovski, Maria Angelica Ehara Watanabe.   

Abstract

The FOXP3 gene encodes a transcription factor thought to be important for the development and function of regulatory T cells (Treg cells). These cells are involved in the regulation of T cell activation and therefore are essential for normal immune homeostasis. Signals from microenvironment have a profound influence on the maintenance or progression of diseases. Thus, Tregs have an important marker protein, FOXP3, though it does not necessarily confer a Treg phenotype when expressed. FOXP3 polymorphisms that occur with high frequency in the general populations have been studied in common multifactorial human diseases. Dysfunction of FOXP3 gene product could result in lack of Treg cells and subsequently chronically activated CD4+ T cells which express increased levels of several activation markers and cytokines, resulting in some autoimmune diseases. In contrast, high Treg levels have been reported in peripheral blood, lymph nodes, and tumour specimens from patients with different types of cancer. The present study discusses the polymorphisms located in intron, exon and promoter regions of FOXP3 which have already been investigated by many researchers. FOXP3 has received considerable attention in attempts to understand the molecular aspect of Treg cells. Therefore, in the present study, the relationship between genetic polymorphism of FOXP3 in Treg-cell role and in disease development are reviewed considering the interactive effect of genetic factors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23640423     DOI: 10.1007/s12041-013-0213-7

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  77 in total

1.  Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1.

Authors:  Masahiro Ono; Hiroko Yaguchi; Naganari Ohkura; Issay Kitabayashi; Yuko Nagamura; Takashi Nomura; Yoshiki Miyachi; Toshihiko Tsukada; Shimon Sakaguchi
Journal:  Nature       Date:  2007-03-21       Impact factor: 49.962

2.  Structure of a domain-swapped FOXP3 dimer on DNA and its function in regulatory T cells.

Authors:  Hozefa S Bandukwala; Yongqing Wu; Markus Feuerer; Yongheng Chen; Bianca Barboza; Srimoyee Ghosh; James C Stroud; Christophe Benoist; Diane Mathis; Anjana Rao; Lin Chen
Journal:  Immunity       Date:  2011-03-31       Impact factor: 31.745

Review 3.  FOXP3 ensembles in T-cell regulation.

Authors:  Bin Li; Arabinda Samanta; Xiaomin Song; Keiji Furuuchi; Kathryn T Iacono; Sarah Kennedy; Makoto Katsumata; Sandra J Saouaf; Mark I Greene
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

4.  Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells.

Authors:  Ye Zheng; Steven Z Josefowicz; Arnold Kas; Tin-Tin Chu; Marc A Gavin; Alexander Y Rudensky
Journal:  Nature       Date:  2007-01-21       Impact factor: 49.962

5.  FOXP3 germline polymorphisms are not associated with risk of breast cancer.

Authors:  Leon Raskin; Gad Rennert; Stephen B Gruber
Journal:  Cancer Genet Cytogenet       Date:  2009-04-01

6.  FOXP3 is a homo-oligomer and a component of a supramolecular regulatory complex disabled in the human XLAAD/IPEX autoimmune disease.

Authors:  Bin Li; Arabinda Samanta; Xiaomin Song; Kathryn T Iacono; Patrick Brennan; Talal A Chatila; Giovanna Roncador; Alison H Banham; James L Riley; Qiang Wang; Yuan Shen; Sandra J Saouaf; Mark I Greene
Journal:  Int Immunol       Date:  2007-06-22       Impact factor: 4.823

Review 7.  Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?

Authors:  Jochen Huehn; Julia K Polansky; Alf Hamann
Journal:  Nat Rev Immunol       Date:  2009-02       Impact factor: 53.106

8.  Indispensable role of the Runx1-Cbfbeta transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells.

Authors:  Akihiko Kitoh; Masahiro Ono; Yoshinori Naoe; Naganari Ohkura; Tomoyuki Yamaguchi; Hiroko Yaguchi; Issay Kitabayashi; Toshihiko Tsukada; Takashi Nomura; Yoshiki Miyachi; Ichiro Taniuchi; Shimon Sakaguchi
Journal:  Immunity       Date:  2009-10-01       Impact factor: 31.745

9.  TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.

Authors:  Liang Zhou; Jared E Lopes; Mark M W Chong; Ivaylo I Ivanov; Roy Min; Gabriel D Victora; Yuelei Shen; Jianguang Du; Yuri P Rubtsov; Alexander Y Rudensky; Steven F Ziegler; Dan R Littman
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

10.  CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation.

Authors:  Hyoung-Pyo Kim; Warren J Leonard
Journal:  J Exp Med       Date:  2007-06-25       Impact factor: 14.307

View more
  32 in total

1.  Foxp3 promoter polymorphism (rs3761548) in breast cancer progression: a study from India.

Authors:  Parveen Jahan; V R Vinish Ramachander; G Maruthi; S Nalini; K Prasanna Latha; T S R Murthy
Journal:  Tumour Biol       Date:  2013-12-13

2.  FOXP3 immunoregulatory gene variants are independent predictors of human papillomavirus infection and cervical cancer precursor lesions.

Authors:  Fernando Cezar-Dos-Santos; Rodolfo Sanches Ferreira; Nádia Calvo Martins Okuyama; Kleber Paiva Trugilo; Michelle Mota Sena; Érica Romão Pereira; Ana Paula Lombardi Pereira; Maria Angelica Ehara Watanabe; Karen Brajão de Oliveira
Journal:  J Cancer Res Clin Oncol       Date:  2019-06-08       Impact factor: 4.553

3.  Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model.

Authors:  Baihao Zhang; Shunsuke Chikuma; Shohei Hori; Sidonia Fagarasan; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-07       Impact factor: 11.205

4.  FOXP3 rs3761548 polymorphism is associated with tacrolimus-induced acute nephrotoxicity in renal transplant patients.

Authors:  Zhuo Wu; Qinxia Xu; Xiaoyan Qiu; Zheng Jiao; Ming Zhang; Mingkang Zhong
Journal:  Eur J Clin Pharmacol       Date:  2016-10-17       Impact factor: 2.953

5.  Association between FOXP3 gene polymorphisms and risk of differentiated thyroid cancer in Chinese Han population.

Authors:  Weichao Jiang; Lei Zheng; Lijuan Xu; Yang Zhang; Xingxin Liu; Lihua Hu; Xiaobei Wang
Journal:  J Clin Lab Anal       Date:  2016-11-28       Impact factor: 2.352

Review 6.  Genetic and Molecular Biology of Multiple Sclerosis Among Iranian Patients: An Overview.

Authors:  Meysam Moghbeli
Journal:  Cell Mol Neurobiol       Date:  2019-09-03       Impact factor: 5.046

7.  Association between rs2294020 in X-linked CCDC22 and susceptibility to autoimmune diseases with focus on systemic lupus erythematosus.

Authors:  Fabio D'Amico; Evangelia Skarmoutsou; Lauren J Lo; Mariagrazia Granata; Chiara Trovato; Giulio A Rossi; Chiara Bellocchi; Maurizio Marchini; Raffaella Scorza; Maria Clorinda Mazzarino; Alon Keinan
Journal:  Immunol Lett       Date:  2016-11-22       Impact factor: 3.685

8.  Overexpression of programmed death ligands in naturally occurring postweaning multisystemic wasting syndrome.

Authors:  Feng Yue; Anchun Cheng; Yanping Zhu; Peng Li; Yanfang Zhang; Guopeng Sun; Mingshu Wang; Xuannian Wang
Journal:  Viral Immunol       Date:  2015-01-16       Impact factor: 2.257

9.  Circulating levels of interleukin-35 in patients with multiple sclerosis: evaluation of the influences of FOXP3 gene polymorphism and treatment program.

Authors:  A Jafarzadeh; M Jamali; R Mahdavi; H A Ebrahimi; H Hajghani; A Khosravimashizi; M Nemati; H Najafipour; A Sheikhi; M M Mohammadi; H Daneshvar
Journal:  J Mol Neurosci       Date:  2014-10-19       Impact factor: 3.444

10.  FOXP3+ T cells are present in kidney biopsy samples in children with tubulointerstitial nephritis and uveitis syndrome.

Authors:  Sari H Rytkönen; Petri Kulmala; Helena Autio-Harmainen; Pekka Arikoski; Kira Endén; Janne Kataja; Tuomo Karttunen; Matti Nuutinen; Timo Jahnukainen
Journal:  Pediatr Nephrol       Date:  2017-09-11       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.